This company has been marked as potentially delisted and may not be actively trading. Nuwellis (CHFS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock CHFS vs. QTI, IRIX, NRXS, NXL, STRR, MOVE, NUWE, TIVC, NDRA, and HSDTShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include QT Imaging (QTI), IRIDEX (IRIX), NeurAxis (NRXS), Nexalin Technology (NXL), Star Equity (STRR), Movano (MOVE), Nuwellis (NUWE), Tivic Health Systems (TIVC), ENDRA Life Sciences (NDRA), and Helius Medical Technologies (HSDT). Nuwellis vs. QT Imaging IRIDEX NeurAxis Nexalin Technology Star Equity Movano Nuwellis Tivic Health Systems ENDRA Life Sciences Helius Medical Technologies QT Imaging (NASDAQ:QTI) and Nuwellis (NASDAQ:CHFS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership, dividends and community ranking. Do institutionals & insiders believe in QTI or CHFS? 24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 65.1% of Nuwellis shares are owned by institutional investors. 75.4% of QT Imaging shares are owned by insiders. Comparatively, 0.6% of Nuwellis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is QTI or CHFS more profitable? QT Imaging has a net margin of 0.00% compared to Nuwellis' net margin of -254.26%. QT Imaging's return on equity of 0.00% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets QT ImagingN/A N/A -65.94% Nuwellis -254.26%-173.61%-131.01% Does the MarketBeat Community favor QTI or CHFS? Nuwellis received 324 more outperform votes than QT Imaging when rated by MarketBeat users. CompanyUnderperformOutperformQT ImagingN/AN/ANuwellisOutperform Votes32469.53% Underperform Votes14230.47% Which has higher earnings and valuation, QTI or CHFS? QT Imaging has higher earnings, but lower revenue than Nuwellis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQT Imaging$4.00M5.43-$4.03MN/AN/ANuwellis$5.51M1.05-$18.11M-$279.280.00 Which has more volatility & risk, QTI or CHFS? QT Imaging has a beta of -0.2, meaning that its share price is 120% less volatile than the S&P 500. Comparatively, Nuwellis has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Does the media favor QTI or CHFS? In the previous week, QT Imaging had 3 more articles in the media than Nuwellis. MarketBeat recorded 3 mentions for QT Imaging and 0 mentions for Nuwellis. QT Imaging's average media sentiment score of 0.78 beat Nuwellis' score of 0.00 indicating that QT Imaging is being referred to more favorably in the media. Company Overall Sentiment QT Imaging Positive Nuwellis Neutral SummaryQT Imaging beats Nuwellis on 8 of the 12 factors compared between the two stocks. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHFS vs. The Competition Export to ExcelMetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.77M$3.26B$5.35B$8.38BDividend YieldN/A1.73%5.22%4.10%P/E Ratio-0.0216.6026.8419.71Price / Sales1.0585.43391.39116.98Price / CashN/A44.0938.2534.62Price / Book0.073.736.794.50Net Income-$18.11M$94.03M$3.23B$248.18M Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHFSNuwellisN/A$0.90-5.8%N/A+272.3%$5.43M$5.51M-0.0266QTIQT ImagingN/A$0.85-1.5%N/A-12.1%$23.00M$4.00M0.00N/AGap DownIRIXIRIDEX0.8078 of 5 stars$1.12-2.6%$2.00+78.6%-62.1%$18.80M$48.67M-1.67120Analyst ForecastNRXSNeurAxisN/A$2.27-2.2%N/A+4.9%$16.38M$2.69M-1.2319News CoverageGap DownNXLNexalin Technology2.7802 of 5 stars$1.20-3.9%$5.00+316.4%+1.7%$16.00M$168,721.00-1.883STRRStar Equity2.9691 of 5 stars$2.49+1.2%N/A-51.1%$8.01M$53.36M-0.97460News CoverageMOVEMovano2.2981 of 5 stars$1.05+16.0%$30.00+2,757.1%-91.3%$7.39M$1.01M-0.2130Trending NewsGap UpHigh Trading VolumeNUWENuwellis2.5045 of 5 stars$0.97-2.0%$17.00+1,652.6%-90.1%$4.24M$8.74M-0.0170TIVCTivic Health Systems0.0924 of 5 stars$4.12-2.6%N/A-45.1%$2.53M$780,000.000.0010Earnings ReportGap DownNDRAENDRA Life Sciences1.6492 of 5 stars$3.25-5.8%$50.00+1,438.5%-100.0%$1.83MN/A0.0020Negative NewsHSDTHelius Medical Technologies0.7474 of 5 stars$4.29+2.1%N/A-78.8%$1.76M$434,000.00-0.6930Positive NewsGap Up Related Companies and Tools Related Companies QTI Alternatives IRIX Alternatives NRXS Alternatives NXL Alternatives STRR Alternatives MOVE Alternatives NUWE Alternatives TIVC Alternatives NDRA Alternatives HSDT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CHFS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
